Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Intravenous immunoglobulin plus corticosteroids prevent coronary artery abnormalities in Kawasaki disease.

Brogan P, Levin M.

Evid Based Med. 2013 Dec;18(6):217-8. doi: 10.1136/eb-2013-101264. Epub 2013 Apr 5. No abstract available.

PMID:
23564929
2.

Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Chen S, Dong Y, Yin Y, Krucoff MW.

Heart. 2013 Jan;99(2):76-82. doi: 10.1136/heartjnl-2012-302126. Epub 2012 Aug 6. Review.

PMID:
22869678
3.

A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.

Chandelia S.

Cardiol Young. 2015 Aug;25(6):1228. doi: 10.1017/S1047951115000487. Epub 2015 Apr 23. No abstract available.

PMID:
25904322
4.

Is there a role for corticosteroids in Kawasaki disease?

Shulman ST.

J Pediatr. 2003 Jun;142(6):601-3. No abstract available.

PMID:
12838185
5.

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.

Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A; RAISE study group investigators.

Lancet. 2012 Apr 28;379(9826):1613-20. doi: 10.1016/S0140-6736(11)61930-2. Epub 2012 Mar 8.

PMID:
22405251
6.

Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis.

Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Pürerfellner H, Liu S, Krucoff MW.

JAMA Pediatr. 2016 Dec 1;170(12):1156-1163. doi: 10.1001/jamapediatrics.2016.2055. Review.

PMID:
27749951
7.

Treatment of Kawasaki disease: corticosteroids revisited.

Newburger JW.

J Pediatr. 1999 Oct;135(4):411-3. No abstract available.

PMID:
10518072
8.

A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.

Yang X, Liu G, Huang Y, Chen S, Du J, Jin H.

Cardiol Young. 2015 Aug;25(6):1182-90. doi: 10.1017/S1047951114002601. Epub 2015 Jan 19. Review.

PMID:
25597708
9.

[Risk stratification and prediction of resistance to intravenous immunoglobulin in Kawasaki disease].

Kobayashi T, Inoue Y, Morikawa A.

Nihon Rinsho. 2008 Feb;66(2):332-7. Review. Japanese.

PMID:
18260333
10.

Kawasaki disease: part II. Complications and treatment.

Bayers S, Shulman ST, Paller AS.

J Am Acad Dermatol. 2013 Oct;69(4):513.e1-8; quiz 521-2. doi: 10.1016/j.jaad.2013.06.040. Review.

PMID:
24034380
11.

Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark.

Patel A, Holman RC, Callinan LS, Sreenivasan N, Schonberger LB, Fischer TK, Belay ED.

Acta Paediatr. 2013 Apr;102(4):385-90. doi: 10.1111/apa.12142. Epub 2013 Jan 21.

PMID:
23278838
12.

[Advance in diagnosis and treatment of intravenous immunogolobulin-resistant Kawasaki disease].

Zhang Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 Apr;11(4):318-21. Review. Chinese. No abstract available.

PMID:
19374823
13.

Response of refractory Kawasaki disease to intravenous methylprednisolone.

Shah I, Prabhu SS.

Ann Trop Paediatr. 2009 Mar;29(1):51-3. doi: 10.1179/146532809X402033.

PMID:
19222935
14.
16.

Resistant Kawasaki disease.

Nachiappan J, May M, Hawker RE, Hong P.

J Paediatr Child Health. 2004 Sep-Oct;40(9-10):576-8. No abstract available.

PMID:
15367156
17.

Predicting coronary aneurysms in Kawasaki disease.

Gersony WM.

Am J Cardiol. 1998 May 1;81(9):1162-4.

PMID:
9605060
18.

Treatment of Kawasaki disease using locally product intravenous immunoglobulin.

Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S656-60.

PMID:
14700163
19.

Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.

Dale RC, Saleem MA, Daw S, Dillon MJ.

J Pediatr. 2000 Nov;137(5):723-6.

PMID:
11060542
20.

Treatment of Kawasaki disease.

Taddio A, Rosé CD.

N Engl J Med. 2007 Jun 28;356(26):2747; author reply 2748. No abstract available.

PMID:
17600908

Supplemental Content

Support Center